PortalPublikationenIn-utero exposure to tenofovir is associated with impaired f...

In-utero exposure to tenofovir is associated with impaired fetal and infant growth

Standard

In-utero exposure to tenofovir is associated with impaired fetal and infant growth : need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply. / Denneman, L; Cohen, S; Godfried, M H; van Leeuwen, E; Nellen, J F; Kuijpers, T W; Pajkrt, D; van de Plas, A; Smit, C; Weijsenfeld, A M; Scherpbier, Henriette J; Bunders, Madeleine J.

in: AIDS, Jahrgang 31, Nr. 4, 20.02.2017, S. 596-598.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Letter › Forschung › Begutachtung

Harvard

Denneman, L, Cohen, S, Godfried, MH, van Leeuwen, E, Nellen, JF, Kuijpers, TW, Pajkrt, D, van de Plas, A, Smit, C, Weijsenfeld, AM, Scherpbier, HJ & Bunders, MJ 2017, 'In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply', AIDS, Jg. 31, Nr. 4, S. 596-598. https://doi.org/10.1097/QAD.0000000000001364

APA

Denneman, L., Cohen, S., Godfried, M. H., van Leeuwen, E., Nellen, J. F., Kuijpers, T. W., Pajkrt, D., van de Plas, A., Smit, C., Weijsenfeld, A. M., Scherpbier, H. J., & Bunders, M. J. (2017). In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply. AIDS, 31(4), 596-598. https://doi.org/10.1097/QAD.0000000000001364

Vancouver

Denneman L, Cohen S, Godfried MH, van Leeuwen E, Nellen JF, Kuijpers TW et al. In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply. AIDS. 2017 Feb 20;31(4):596-598. https://doi.org/10.1097/QAD.0000000000001364

Bibtex

@article{3f8df0d42f59447394108e49193481af,
title = "In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply",
keywords = "Anti-HIV Agents, Follow-Up Studies, HIV Infections, Humans, Infant, Infectious Disease Transmission, Vertical, Pregnancy Complications, Infectious, Tenofovir",
author = "L Denneman and S Cohen and Godfried, {M H} and {van Leeuwen}, E and Nellen, {J F} and Kuijpers, {T W} and D Pajkrt and {van de Plas}, A and C Smit and Weijsenfeld, {A M} and Scherpbier, {Henriette J} and Bunders, {Madeleine J}",
year = "2017",
month = feb,
day = "20",
doi = "10.1097/QAD.0000000000001364",
language = "English",
volume = "31",
pages = "596--598",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

RIS

TY - JOUR

T1 - In-utero exposure to tenofovir is associated with impaired fetal and infant growth

T2 - need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants: author's reply

AU - Denneman, L

AU - Cohen, S

AU - Godfried, M H

AU - van Leeuwen, E

AU - Nellen, J F

AU - Kuijpers, T W

AU - Pajkrt, D

AU - van de Plas, A

AU - Smit, C

AU - Weijsenfeld, A M

AU - Scherpbier, Henriette J

AU - Bunders, Madeleine J

PY - 2017/2/20

Y1 - 2017/2/20

KW - Anti-HIV Agents

KW - Follow-Up Studies

KW - HIV Infections

KW - Humans

KW - Infant

KW - Infectious Disease Transmission, Vertical

KW - Pregnancy Complications, Infectious

KW - Tenofovir

U2 - 10.1097/QAD.0000000000001364

DO - 10.1097/QAD.0000000000001364

M3 - Letter

C2 - 28118236

VL - 31

SP - 596

EP - 598

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 4

ER -